GSA Capital Partners’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q1
Sell
-23,393
Closed -$212K 2016
2013
Q4
$212K Buy
+23,393
New +$212K 0.02% 1433